Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Licensing

Licensing

posted on Apr 01, 2008 12:32PM
I suspect that the cost of a license post PTSC financials remains the same. Which is probably why licensing has slowed.   And that makes sense.  The Markman and trial settlement each increased the risk level for fence-sitters.  How could TPL ask for more $ based on another company's financial reporting, which does not impact on risk? The next risk event will be USPTO or Appeals Court ruling.  I suspect that cost of a license will remain what it is until then.  We may not see any signings before 4/9.  However, I trust on 4/10 the fence-sitters will view the present cost of proceeding with a license much differently.     Opty
Share
New Message
Please login to post a reply